Joel Farley, PhD, is an assistant professor in the Division of Pharmaceutical Outcomes and Policy. His research concentrations are in the areas of pharmacoepidemiology and pharmaceutical outcomes. His primary research interest relates to the evaluation of public policies used to manage prescription medications. In particular, Dr. Farley is interested in the effect of Medicaid prescription cost-containment policies on vulnerable populations.  

Dr. Farley has experience working with both primary and secondary data. He has particular expertise in the use of secondary data sources including the Medical Expenditure Panel Survey, private health plan data, and State Medicaid Research Files. Dr. Farley has publications ranging from methodological considerations in outcomes research to commentaries on public policy issues.  However, his primary publication stream relates to examinations of the decision to use medications among select patient populations. These investigations are used to identify issues of effectiveness, access, and affordability of medications among different patient populations.

Click for full CV

Click here to view this member's research page.

Publications

Farley JF, Devine JD, Hadsall RS.  “Professional implications of the expansion of pharmacy-based medical clinics”.  Journal of the American Pharmacists Association (In press)

Lu YJ, Farley JF, Hansen RA. (2006) “Promotion and market share in the proton pump inhibitor market: A case study”. The Journal of Pharmaceutical Marketing and Management.  (In press)

Farley JF, Cline RR, Gupta K. (2006) “Racial variation in antiresorptive medications use: results from the 2000 Medical Expenditure Panel Survey (MEPS)”. Osteoporosis International.  17(3): 395-404.

Devine JW, Cline RR, Farley JF. (2006) “What is the benefit of a market without generic biologics?  the uncertain future of generic competition in the biopharmaceutical market.”  Journal of the American Pharmacists Association. 46(2): 193-201.

Farley JF, Harley CR, Devine JW. (2006) “A comparison of comorbidity measurements to predict health expenditures.”  American Journal of Managed Care. 12(2): 110-117.

Devine JW, Farley JF, Hadsall RS. (2005) “Patterns and predictors of prescription medication use in the management of headache.” Headache: The Journal of Head and Face Pain. 45(9):1171-1180.

Cline RR, Farley JF, Hansen RA, Schommer JC.  (2005) “Osteoporosis beliefs and antiresorptive medication use.” Maturitas. 50:196-208.

Farley JF, Cline RR, Hansen RA. (2004) “Resorptive drug use patterns among Minnesota females: results of a statewide survey.” American Journal of Health-System Pharmacy. 61:1577-1585.

Presentations

Devine JW, Hadsall RS, Farley JF.  Extending Matching Estimators of Causal Effects to Consider Unobserved Variable Bias: An Application of Sensitivity Analysis.  Poster presentation at the Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Philadelphia, PA, May 20-24, 2006.

Farley JF. Payment and Utilization Effects of a Step Therapy Prior Authorization Program for Atypical Antipsychotic Medications.  Podium presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, San Francisco, CA, March 17 to 21, 2006.

Farley JF.  A Comparison of the Elixhauser and Charlson Indices to Control for Confounding in Health Outcomes Studies.  Poster presentation at the Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Washington, D.C. May 15 to 18, 2005.

Devine JW, Farley JF, Hadsall R. Distribution and Determinants of Prescription Medication Use Among Individuals with Headache in the United States.  Podium presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, Orlando, Fl, April 1 to 5, 2005.

Farley JF, Cline RR, Gupta K.  An Examination of Racial Variations in Prescribing of Antiresorptive Medications using the 2000 Medical Expenditure Panel Survey (MEPS). Podium presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, Orlando, Fl, April 1 to 5, 2005.

Cline RR, Farley JF, Hansen RA, Schommer JC.  Osteoporosis beliefs and antiresorptive medication use.   Podium presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, Seattle, WA, March 26 to 30, 2004.

Farley JF, Cline RR, Hansen RA. Resorptive drug use patterns among Minnesota females: results of a statewide survey.  Poster presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section Seattle, WA, March 26 to 30, 2004.

Farley JF, Hadsall R, Novak J. Perceptions and reporting of errors in community pharmacy practice.  Poster presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, New Orleans, LA, March 28 to April 1, 2003.